About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, March 15th, 2018

The QualityStocks
Daily Stock List


Viking Energy Group, Inc. (VKIN)

FatCat Stocks, Wall Street Beauties, WINNINGOTC, SMS Penny Picks, Greenbackers, SmallCapFinancialWire, Daily Stock Motion, Penny Pick Insider, Penny Stocks VIP, and Undiscovered Equities reported earlier on Viking Energy Group, Inc. (VKIN), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Established in 1989, Viking Energy Group, Inc. is an independent exploration and production corporation. The Company targets under-valued assets with realistic appreciation potential. Viking Energy owns oil and gas leases in Kansas, Missouri, and Texas, Louisiana, Mississippi and Alberta. The Company is based in New York, New York. Viking Energy Group lists on the OTC Markets’ OTCQB.

The Company previously went by the name Viking Investments Group, Inc. It changed its name to Viking Energy Group, Inc. in March of 2017.

In essence, Viking Energy purchases interests in producing, long-life, low-cost oil properties producing positive cash-flow. It is not considering speculative exploration programs.

The Company targets properties with current production and untapped reserves for future benefit. Viking Energy concentrates on acquiring under-valued, producing properties from distressed vendors or those considered as non-core assets by larger sector participants.

Viking Energy, via its wholly-owned subsidiary, Mid-Con Petroleum, LLC, owns a working interest in 7 producing oil leases with access to the mineral rights (oil and gas) regarding roughly 800 acres of property in Miami and Franklin Counties in Eastern Kansas. Its working interests (WI’s) in the leases range from 68 percent to 100 percent.

In Alberta, Viking Energy has a Joint Venture (JV) with Tanager Energy, Inc. The Company’s investment with Tanager Energy includes a 50 percent WI in the Joffre Project, comprising 4 oil wells and one water injection well. Tanager Energy’s initial project incorporates the Leduc D-3 B Pinnacle Reef in Central Alberta, which is where the Joffre D-3 Oil Project is situated (the Joffre Project).

In Missouri, Viking Energy owns a 100 percent W1 (approximately NRI 83 percent) in 31 leases, with access to the mineral rights (oil and gas) concerning approximately 5,500 acres of property in Cass and Bates Counties.

Viking Energy has acquired additional working interests in an assortment of oil and gas-related leases in Eastern Kansas. On September 11, 2017, the Company, through a wholly-owned subsidiary, Mid-Con Drilling, LLC, acquired a 90 percent WI in four new oil and gas leases in Anderson County in Eastern Kansas, comprising about 980 acres of property.

Viking Energy Group announced in October 2017 that it acquired additional WI’s in different oil and gas-related leases in Kansas. This was its third acquisition in less than 30 days. On October 4, 2017, the Company, via Mid-Con Drilling, acquired, effective September 1, 2017, an 80 percent WI in six new oil and gas leases in Riley, Geary, and Wabaunsee Counties in Kansas.

This past January, Viking Energy Group announced that it acquired, via its wholly-owned subsidiary, Mid-Con Development, a majority working interest in a number of oil leases in Ellis and Rooks Counties in Kansas.

Features of the acquired assets include more than 40 oil leases, consisting of roughly 3,300 acres. Cumulative oil production from the acquired leases is greater than 6,400,000 barrels. Haas Petroleum LLC has been engaged to operate the assets on behalf of Mid-Con. Haas Petroleum is a fourth-generation oil and gas company.

Viking Energy Group, Inc. (VKIN), closed Thursday's trading session at $0.1501, even for the day. The average volume for the last 60 days is 20,895 and the stock's 52-week low/high is $0.09/$0.34.

Graphene 3D Lab, Inc. (GPHBF)

OTC Markets, Agora Financial, and Stockhouse reported on Graphene 3D Lab, Inc. (GPHBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Graphene 3D Lab, Inc., via its wholly-owned subsidiary, Graphene Laboratories, Inc., develops, manufactures, and markets proprietary graphene-based nanocomposite materials for varied kinds of 3D printing. This includes fused filament fabrication. In addition the Company engages in the manufacture and sale of graphene materials and nanocomposite enhanced polymers through Graphene Laboratories.

Last week, Graphene 3D Lab announced that it completed its facility move to the new industrial facility at 760 Koehler Avenue, Ronkonkoma, State of New York. The 8,000 sq. ft. facility is in a tech park close to Long Island MacArthur Airport. It is approximately 30 miles from Graphene 3D Lab’s former Calverton facility.

The Company’s go-to-market product is Conductive Graphene Filament. Conductive Graphene Filament brings users the ability to 3D print circuitry and sensors for electronic applications. Graphene 3D Lab has its Industrial Materials Division to commercialize graphene composite materials. Graphene is a single-layer of carbon atoms. Graphene is considered a wonder-material for its high strength, conductivity, and ultra-light-weight.

Furthermore, Graphene 3D Lab engages in the design, manufacture, and marketing of 3D printers and related products for domestic and international customers. It focuses on the development and commercialization of technologies that improve the capabilities of 3D printing.

The Company’s 3D printing division provides a suite of specialty fused fabrication filaments. In addition, Graphene 3D Lab owns a new proprietary technology encompassing the preparation and separation of graphene's atomic layers.

Graphene 3D Lab announced in 2017 the commercial release of two new additions to the G6-Epoxy™ product line of advanced adhesive materials. The product line includes unique carbon-silver adhesive materials. These are built on technology that has undergone development by the Company’s Industrial Division. The new epoxies are highly electrically conductive adhesives with a proprietary formula based on the combination of graphene and silver fillers and other additives.

Graphene 3D Lab has released the Graphene-HIPS 3D Printing Filament. Graphene-HIPS is a distinctly engineered and innovative semi-flexible FDM 3D Printing material reinforced with graphene. The design of it is for high performance 3D printing. The FDM material exhibits premier interlayer adhesion, toughness, and also premier impact resistance.

In February, Graphene 3D Lab announced it filed a patent application entitled "Method and System for Recovering and Utilizing Heat Energy Produced by Computer Hardware in Blockchain Mining Operations" with the United States Patent and Trademark Office (USPTO). This invention introduces a pioneering new technology for recuperating the thermal energy produced in the computation and Blockchain operation, using that recovered thermal energy in heating and/or refrigeration modules utilizing graphene.

With the method invented by Graphene 3D Lab, the thermal energy produced by the computational hardware is harvested and converted into heating and/or refrigeration solutions with modules utilizing graphene. The solutions can be used for air conditioning or food preservation. Therefore, this lessens electric energy consumption while supporting the Blockchain network or cryptocurrency mining.

Graphene 3D Lab, Inc. (GPHBF), closed Thursday's trading session at $0.13485, down 1.57%, on 247,068 volume with 15 trades. The average volume for the last 60 days is 109,856 and the stock's 52-week low/high is $0.068/$0.2141.

Research Solutions, Inc. (RSSS)

Wall Street Resources and Marketbeat reported on Research Solutions, Inc. (RSSS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Research Solutions, Inc. is an innovator in providing cloud-based solutions for scientific research. It is a pioneer in cloud-based SaaS (Software-as-a-Service) research intelligence products and services for research-intensive organizations. OTCQB-listed, Research Solutions has its headquarters in Encino, California.

The Company’s cloud-based SaaS platform provides customers with on demand access to, and augmented data from, tens of millions of scientific, medical, and technical (STM) documents. This is in addition to tens of millions of articles previously published.

Research Solutions has its wholly-owned subsidiary Reprints Desk, Inc. Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research.

Reprints Desk and Altmetric LLP earlier agreed to integrate Altmetric badges to scholarly content obtained via Reprints Desk's award-winning research retrieval platform Article Galaxy. Altmetric is a top research metrics provider.

Reprints Desk has signed separate reseller agreements with Ritme and Alfasoft to deliver new tools and services that address the total range of knowledge acquisition and information management requirements of researchers in scientific, technical, as well as medical (STM) fields.

Research Solutions announced in November of 2017 that its wholly-owned subsidiary, Reprints Desk, was named to EContent Magazine's list of 100 digital content industry leaders for the 7th consecutive year in the Distribution and Delivery category. EContent Magazine's annual list is decided by a panel of 11 information industry experts.

In January 2018, Research Solutions announced that it appointed Mr. Roy W. Olivier to its Board of Directors. Mr. Olivier replaces Jan Peterson, who is retiring. Mr. Olivier presently serves as President and Chief Executive Officer (CEO) of ARI Network Services (previously NASDAQ: ARIS). ARI Network Services is a provider of an award-winning suite of SaaS tools and marketing services.

Last month, Research Solutions reported financial results for its Fiscal Q2 ended December 31, 2017. Total Revenue grew 12 percent to $6.8 million. Total Gross Margin was up 280 basis points to 25.4 percent. Net Loss from Continuing Operations was $0.7 million, or $(0.03) per share, versus a Net Loss of $1.1 million, or $(0.05) per share.

Mr. Peter Derycz, President and CEO of Research Solutions, said, "Our second quarter showed continued robust growth in our SaaS-based Platforms offering, which helped support a strong quarter in our Transactions business. Version 2.0 of our Article Galaxy Platform went live in December and the early feedback on user experience has been quite positive. We look forward to completing the migration by March and implementing other major framework additions, like self-registration, in the next several months.”

Research Solutions, Inc. (RSSS), closed Thursday's trading session at $1.28, even for the day, on 119 volume with 1 trade. The average volume for the last 60 days is 7,977 and the stock's 52-week low/high is $0.66/$1.325.

Molori Energy, Inc. (MOLOF)

InvestorsHub, Stockhouse, Streetwise Reports, and MarketWatch reported on Molori Energy, Inc. (MOLOF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Molori Energy, Inc. has current operations in the Texas Panhandle West Field. The Company’s operating team that is based in Borger, Texas, has extensive experience in the oil and gas industry in the Texas Panhandle. Molori Energy's business model is to deliver sustainable growth in shareholder value through centering on exploiting its existing reserves, commercializing and developing discoveries, and pursuing selective acquisitions.

An oil and gas production company, Molori Energy is headquartered in Vancouver, British Columbia. Thee Company previously went by the name Taipan Resources, Inc. It changed its corporate name to Molori Energy Inc. in January of 2017.

The Company’s strategy has been to engage in low-risk well reactivations in the Texas Panhandle to produce steady cash flows. Greater than 60 wells have been reactivated so far. These are producing from the prolific Brown Dolomite formation.

At present, Molori Energy owns a 25 percent working interest (WI) in certain leases positioned in the bifurcated Texas panhandle, operated by its Texas-based partner Ponderosa Energy, LLC. Molori Energy has 165 producing (PDP) wells and an inventory of about 202 non-producing wells (PDNP) for a total of 367 wells. It is working to RTP (Return to Production) the PDNP wells through performing simple re-works or re-completions.

The assets include low-decline, PDP weighted reserves primarily in the West Panhandle Field of the Hugoton Basin of Texas. These assets are roughly 50 percent oil and 50 percent liquid rich gas (HIGH BTU premium gas) mainly located in Carson, Gray, and Hutchinson Counties of District 10.

Molori Energy and Ponderosa Energy have identified a development opportunity in the Red Cave formation. The formation is common throughout its leases at a shallower depth of 2,100’ to 2,300’. Improved fracing technologies and completion techniques have shown the Red Cave to be an economic development target.

Molori Energy announced in October of 2017 the signing of a definitive agreement to purchase an additional 25 percent WI in certain oil and gas leases from its Texas-based operating partner, Ponderosa Energy. This latest acquisition, combined with the 25 percent interest Molori presently has in these same leases, will bring the Company’s overall interest to 50 percent.

Molori Energy also announced in October the signing of a definitive agreement to secure a 75 percent WI in certain oil and gas leases, known formally as the "Red Cave Leases" in District 10, Texas. This acquisition of these leases, encompassing 11,000 acres with access to Red Cave, and with access to other formations, is an important milestone of Phase 1 of the Company’s development plan.

Recently, Molori Energy announced that it drilled to target depth the first of eight planned Red Cave Appraisal wells ('The Thompson 23-1R Well') upon its Moore County, Texas acreage upon which Molori Energy now holds a 75 percent WI. The 23-1R well was drilled to a total measured depth of roughly 2,500 feet and was immediately logged.

Upon evaluation of the open hole logs late in December 2017, it was determined that production pipe should be run on the Thompson 23-1R. On January 20, 2018, the well was successfully fracked with around 400,000 gallons of slick water and 250,000 lbs of sand.

Last month, Molori Energy announced a commercial oil discovery on its acreage in Moore County, Texas. The "Thompson 23-1R" well, operated by Molori Energy, is a northern step-out well drilled in December of 2017. The Thompson 23-1R well is directly north of the active development area of Adams Affiliates.

Mr. Joel Dumaresq, Molori Energy Chief Executive Officer, said, "We are extremely pleased with the 'discovery' and the initial results of our Thompson 23-1R well and frac into the Red Cave. The oil to water ratio continues to improve daily as we recover the water injected with the frac, and as a result we are experiencing daily increases in production."

Molori Energy, Inc. (MOLOF), closed Thursday's trading session at $0.2175, down 3.76%, on 20,670 volume with 11 trades. The average volume for the last 60 days is 40,951 and the stock's 52-week low/high is $0.175/$0.52.

U.S. Stem Cell, Inc. (USRM)

TradingView, InvestorsHub, MarketWatch, and Money Morning reported on U.S. Stem Cell, Inc. (USRM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

U.S. Stem Cell, Inc. is a developing business in the regenerative medicine/cellular therapy industry. The Company is a developer of novel autologous cell therapies, and a provider of physician based stem cell therapies to human and animal patients. U.S. Stem Cell has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. U.S. Stem Cell is headquartered in Sunrise, Florida. The Company previously went by the name Bioheart, Inc. It changed its corporate name to U.S. Stem Cell, Inc. in October 2015.

The Company’s focus is on the discovery, development, and commercialization of cell based therapeutics, which prevent, treat, or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

U.S. Stem Cell’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services. Its business additionally includes cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.

U.S. Stem Cell’s lead product candidate is MyoCell®. This is a muscle stem cell therapy intended to improve cardiac function months or even years after a patient has suffered severe heart damage because of a heart attack.

MyoCell SDF-1 has received approval from the Food and Drug Administration (FDA) to begin human clinical trials. The intention of MyoCell SDF-1 is to be an improvement to MyoCell. Concerning its AdipoCell product, the Company has applied to the FDA to begin trials using adipose derived stem cells or AdipoCell™ in patients with chronic ischemic cardiomyopathy.

U.S. Stem Cell announced has developed a strategic alliance with Advanced Stem Cell Rx (ASC). This includes the development of autologous stem cell treatment centers across the U.S. ASC is a U.S. based provider of regenerative medicine programs.

This past January, U.S. Stem Cell announced it reached an important milestone of 10,000 kit sales of its proprietary Adipocell™ product. This is a direct result of the Company’s relationships with 287 clinics in the U.S. and 700-plus physicians globally offering the Company’s proprietary stem cell products and services.

Recently, U.S. Stem Cell announced that it is experiencing great demand for stem cell treatments at its clinics. This is a trend reflected in the 106 percent increase in Revenues during Q3. This is continuing due to rapidly growing demand from the marketplace.

U.S. Stem Cell, Inc. (USRM), closed Thursday's trading session at $0.056, down 5.98%, on 940,767 volume with 90 trades. The average volume for the last 60 days is 2,263,703 and the stock's 52-week low/high is $0.016/$0.1793.

Acorn Energy, Inc. (ACFN)

Wall Street Resources, Wealthpire, Inc., SmarTrend Newsletters, MegaPennyStocks, Catalyst IR, Marketbeat, and Hit and Run Candle Sticks reported earlier on Acorn Energy, Inc. (ACFN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Acorn Energy, Inc. is a holding company based in Wilmington, Delaware. It is a provider of machine-to-machine, Internet of Things (IoT) remote monitoring and control systems and services. Acorn has two portfolio companies. These are OmniMetrix™, Inc. and DSIT Solutions Ltd..

The Company has an 80 percent equity stake in OmniMetrix. Acorn consolidates its assets, liabilities and results of operations. Acorn has a 41.2 percent equity stake in DSIT Solutions, which it accounts for under the equity method.

Acorn Energy’s OmniMetrix™ remotely monitors emergency back-up power generation systems to increase their reliability. OmniMetrix™ is the leader and pioneer in M2M wireless remote monitoring, control and diagnostics for pipelines and critical equipment.

OmniMetrix is a solution for making critical systems more reliable. The Company is a solution for pipelines and critical facilities around the world. This includes cell towers, medical facilities, data centers, public transportation systems, and federal, state, and municipal government facilities.

Acorn Energy’s DSIT Solutions provides security solutions from underwater threats to naval and marine based energy assets. DSIT Solutions specializes in the science of sonar and underwater acoustics. It develops advanced Acoustic Intelligence (ACINT) measurement and analysis applications. The Company’s Shield™ family of Underwater Security Systems provides automatic Diver Detection Sonars for protection of valuable coastal and offshore sites.

This past November, Acorn Energy announced results for its Q3 ended September 30, 2017. The Company’s financial results reflect the deconsolidation of DSIT’s operating results following the sale of a portion of Acorn’s ownership in April 2016. DSIT’s operating results were fully consolidated for the period January 1 through April 21, 2016.

Because of the growth in its OmniMetrix subsidiary, Acorn Energy’s Q3 2017 Revenue rose 15 percent to $1,085,000 from $942,000 in Q3 2016. Mainly reflecting the impact of the DSIT deconsolidation in April of 2016, Acorn Energy’s Revenue for the first nine months of 2017 decreased to $3,226,000 from $7,618,000 in the comparable 2016 period. First nine months’ Revenue included $5,074,000 of DSIT revenue in 2016.

The Company reported Q3 2017 Net Income attributable to Shareholders of $236,000, or $0.01 per share. This is in comparison to Net Income of $652,000, or $0.02 per share, in Q3 of 2016.

Acorn Energy, Inc. (ACFN), closed Thursday's trading session at $0.2965, up 14.04%, on 28,307 volume with 12 trades. The average volume for the last 60 days is 74,372 and the stock's 52-week low/high is $0.149/$0.42.

Aspen Group, Inc. (ASPU)

TheMicrocapNews, Greenbackers, TaglichBrothers, Stock News Now, and RedChip reported earlier on Aspen Group, Inc. (ASPU), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Aspen Group, Inc. is a for-profit post-secondary education company. Aspen Group owns two accredited universities. These are Aspen University and United States University. Aspen Group is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQB.

The mission of Aspen University is to offer any motivated college-worthy student the opportunity to receive a high quality, responsibly priced distance-learning education to realize sustainable economic and social benefits for themselves and their families. Aspen University’s dedication is to provide the highest quality education experiences taught by top-tier faculty. Of note is that 54 percent of Aspen University’s faculty hold doctoral degrees.

Degrees offered by Aspen University include Associates, Bachelor’s, Master’s, Doctoral, and Certificates. Aspen University has its School of Professional Studies, School of Nursing, School of Education, School of Management, School of Information Technology, and College of Arts and Sciences.

United States University started its institutional history in 1997 as InterAmerican College in National City, California. The school was renamed to United States University in 2010.

United States University recently moved its campus into the heart of San Diego, California. It is regionally accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges. United States University offers Bachelor and Master level degree programs in nursing, education, health science, as well as business & management.

In July of 2017, Aspen Group announced Aspen University’s launch of the Doctor of Nursing Practice (DNP) in Leadership online degree program. The design of the DNP degree is to be a practice-centered program that combines a scholarly approach to the discipline of nursing. The program prepares advanced practice nurses and educators to lead their organizations and the next generation of nurses.

Aspen Group will host a conference call to discuss its Fiscal Year 2018 Q3 (ending January 31, 2018) financial results and business outlook today - March 15, 2018. The Company will issue a press release reporting results after the market closes today.

Aspen Group, Inc. (ASPU), closed Thursday's trading session at $7.92, down 0.50%, on 12,596 volume with 60 trades. The average volume for the last 60 days is 37,638 and the stock's 52-week low/high is $3.78/$9.61.

biOasis Technologies, Inc. (BIOAF)

OTC Markets Group, SmallCapFinancialWire, and PennyStocks24 reported on biOasis Technologies, Inc. (BIOAF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

biOasis Technologies, Inc. focuses on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The Company is developing and commercializing the xB3 platform, its proprietary blood-brain barrier delivery technology, to address unmet medical needs in the treatment of central nervous system (CNS) diseases and disorders.

A biopharmaceutical enterprise, biOasis Technologies is based in Richmond, British Columbia. The Company also has offices in the State of Connecticut. biOasis Technologies’ lists on the OTC Markets Group’s OTCQB.

The delivery of therapeutics across the BBB represents the single greatest challenge in treating neurological disorders. biOasis Technologies’ Transcend Platform consists of a varied set of peptide carriers and linkers. These, together, provide transport solutions for a variety of CNS therapeutics.

These include monoclonal antibodies, enzymes, small molecules, and different types of gene therapies. Transcend was discovered in the 1990’s in Dr. Wilfred Jefferies’s laboratory at the Michael Smith Laboratories at The University of British Columbia.

Transcend is founded on the naturally occurring human transport protein, melanotransferrin, also named MTf, CD228 and p97. MTf is found at low concentrations in the blood. MTf is able to cross the BBB by way of a process named Receptor Mediated Transcytosis where MTf molecules attach to receptors on the cells of the BBB and is then pulled through the cells and into the brain. With the Company’s proprietary Transcend carrier, the MTf protein can be attached to therapeutics of different sizes and types.

The Transcend Platform is now available to be licensed by biotechnology and pharmaceutical companies for the advancement of their neurotherapeutic programs. Regarding licensing opportunities, the Transcend Platform’s extensive patent structure provides licensees with premier protection of their intellectual property (IP) - with the opportunity to further protect fusion proteins and conjugates developed within the terms of their biOasis Transcend Platform licenses.

The Transcend Platform has achieved a significant high level of success in dozens of studies at greater than twenty third-party institutions and pharmaceutical companies. biOasis Technologies has acquired full patent protection for its Transcend group of peptide carriers and linkers.

The Transcend-peptide platform will now be referred to as the xB3 platform. It is part of the Company’s patented portfolio that is revolutionizing therapeutic brain-drug delivery.

biOasis Technologies is fully dedicated to advancing CNS drug development in association with academic institutions and pharmaceutical companies. The Company is also dedicated to engaging in the commercialization of its platform technologies with licensing opportunities available to the pharmaceutical industry for brain drug delivery.

biOasis Technologies, Inc. (BIOAF), closed Thursday's trading session at $0.4675, even for the day. The average volume for the last 60 days is 4,844 and the stock's 52-week low/high is $0.465/$0.935.

HealthLynked Corp. (HLYK)

InvestorsHub and OTC Markets reported on HealthLynked Corp. (HLYK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, HealthLynked Corp. focuses on improving healthcare services for patients and physicians. The Company’s technology cuts wait times with online scheduling of appointments and real-time appointments by local providers. Its technology also provides easy access to an individual’s and their family's updated medical records. HealthLynked is headquartered in Naples, Florida. The Company commenced trading on the OTC Markets Group’s OTCQB in May 2017.

HealthLynked centers on improving healthcare through connecting patients with their healthcare providers. The HealthLynked Network focuses on the efficient, secure exchange of medical information between patients and their healthcare providers.

The cloud-based HealthLynked Network lets patient's medical records move with them. This is so one’s medical records are not fragmented in manifold healthcare systems and/or EHR systems.

HealthLynked profile information safeguards that doctors don't prescribe potentially harmful medications in case a patient forgets to mention one or more present medications while talking to their doctor. Moreover, the HealthLynked Healthcare Summary page allows patients to keep their medical records updated. This helps physicians to be more productive and provide valid medical care.

Healthcare experts can easily be in touch with patients. They can provide their advice in case of emergencies via the Telemedicine Portal. The HealthLynked Healthcare Summary permits patients to maintain a complete medical profile in coordination with physicians. All information is systematically categorized. As a result, physicians have a total overview of patient health without them having to fill unnecessary paperwork.

This past September, HealthLynked announced it has created more than 880,000 HealthLynked Provider base profiles for every physician in the United States. The creation of the HealthLynked provider network is a vital step in allowing the Company’s patient members to search, geo-locate, and ultimately "Lynk" to any healthcare provider anywhere in the U.S.

Last month, HealthLynked announced its Q3 2017 financial results. It reported revenue of $480,723, and an operating loss of $512,153, which included roughly $135,500 of legal, accounting and other expenses related to the Company’s continuing public filings and investor relations cost and about $158,500 of incremental salary, benefits and other costs related to investment in initial sales and marketing efforts, and software development of the HealthLynked Network.

This was offset by a decrease in Naples Women’s Center’s general and administrative expenses of roughly $45,000, versus Q3 of 2016. The results compare with revenue of $516,798 and an operating loss of $482,570 in Q2 of 2016.

HealthLynked Corp. (HLYK), closed Thursday's trading session at $0.10, up 25.00%, on 10,000 volume with 1 trade. The average volume for the last 60 days is 33,846 and the stock's 52-week low/high is $0.03/$0.90.


The QualityStocks
Company Corner



The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF). Today, FANDOM SPORTS Media Corp. closed trading at $0.1146, even for the day. The stock’s average daily volume over the past 60 days is 25,365, and its 52-week low/high is $0.025/$0.3911.

FANDOM SPORTS Media (CSE:FDM) (OTC:FDMSF) (FRANKFURT:TQ42) today announces the contracting of HHS Technology Group (“HHS”) as a result of the successful testing of the Company’s proof of concept on HHS’s US Government Blockchain architecture design and test platform. Also today, NetworkNewsWire issued a report on the company detailing how FDMSF taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric "argument engine" measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards.

Building on the company's tag line – "Pick a Fight" – the FANDOM SPORTS app provides an always fresh, authentic rush of deeper-than-surface interactive content that resonates with the targeted age demographic of 18-34. Intense sports fans aren't afraid of stepping up to the plate to engage other users by unleashing their opinions within the app's structured debate resolution tool coined "FanFights." Sports-loving fans can explore, gloat, vote, invite friends, create provocative FanFight topics and play to win while inside the FANDOM SPORTS app, which is currently available in the Apple App store and coming to the Google Play store imminently. The company's self-learning algorithm predicts and collects user preferences while building relevant personalized FanFight channels, bringing the concept of competitive, in-your-face conversation to a whole new level of sports entertainment.

The FANDOM SPORTS app is free to play (F2P) with in-app purchase and subscription capabilities. The gaming aspect of the ecosystem is built on behavioral economics and delivers multiple revenue streams by maximizing average revenue per daily active user (ARPDAU) and user-generated content (UGC), with select placement of high-impact video and moment-based marketing as part of the brand-sponsored FanFights and in-app offers. The global platform enables applications (either FANDOM SPORTS created or 3rd party apps) to be operated in partnership with leading sports themed brands, leagues, and service providing companies within three verticals – live action, eSports, & fantasy – from around the world by supplying "interactive sports entertainment" to fans. The FANDOM SPORTS platform creates a bullet-proof snapshot of the app's fan base through a Blockchain supported "PlayerCard" in tandem with the "Engagement Score", which doubles as an invaluable acquisition and retention tool for its business operators. FANDOM SPORTS hosted transactions are placed on the distributed ledger, making them immutable and public to verified users interacting within the business ecosystem. Tracking this digital footprint provides extremely valuable metadata generated by users' very dynamic behavior and sports passion.

FANDOM SPORTS' Brand and Sponsorship partners are harnessing the affluent sports fans age 18-34 with integrated marketing content and service experience. The moments-based marketing integration will translate through FanCoin redemption, in exchange for items provided by programs established by FANDOM SPORTS and its clients. These programs are a key part of the business model and covers, as an example, the following partners; Sports Leagues, TelCo's service offerings, and Content owners (i.e. FANDOM SPORTS provides new paying customers to the owners of pay-per-view platforms).

"Pick A Fight. Talk Trash. Get Rewarded."

FANDOM SPORTS Media is an entertainment company that aggregates, curates and produces unique fan-focused content.

The FANDOM SPORTS App is the Company's core product, which is the ultimate destination for unfiltered raw sports talk. The app allows passionate sports fans to unleash their primal sports passions, pick fights and earn rewards.

So download the app and bring your crew. Talking trash is better with friends. The more you invite, the more FanCoins you earn.

You may also visit the Company's website at www.fandomsportsmedia.com or contact them directly at info@fandomsportsmedia.com.


The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond the Company's control. Some of these risks and uncertainties may be described in the Company's corporate filings (posted at www.sedar.com).

The Company has no intention or obligation to update or revise any forward-looking statements due to new information or events. Disclaimer

FANDOM SPORTS Media Corp. Company Blog

FANDOM SPORTS Media Corp. News:

FANDOM SPORTS Secures US Government Service Provider as Back-end Technology Partner

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) is “One to Watch”

Fandom Sports Releases Android BETA App Way Ahead of Schedule – Friendly User Testing Comin’ in Hot

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.8678, up 9.16%, on 206,583 volume with 180 trades. The stock’s average daily volume over the past 60 days is 286,487, and its 52-week low/high is $0.3148/$1.3041.

Global society’s growing dependence on smartphones and other new technology, as nearly essential elements of daily routine, has become the foil of comedy platforms and reformative movements that offer a getaway from modern connectivity, but there’s no denying the importance of Internet-enabled tech gadgets to consumers, as well as the industries that supply them. That’s especially visible in the international rush to secure supplies of cobalt, a rare mineral that helped revolutionize the way high-tech battery cathodes move electrons in a more efficient way to minimize overheating problems. Amid the trend, Canadian company First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) is pursuing its goal of becoming the largest pure-play cobalt exploration and development company in the world.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Turns Canadian Property into Global Trendsetter in Smart, Ethical Mining

First Cobalt Announces Friendly Acquisition of US Cobalt

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Offers Ethical Alternatives to Conflict Minerals

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $0.8447, up 0.80%, on 95,592 volume with 71 trades. The stock’s average daily volume over the past 60 days is 302,615 and its 52-week low/high is $0.543/$1.5835.

MGX Minerals Inc. (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is pleased to announce that as a result of the recently announced positive Preliminary Economic Assessment for the production of 161,000 net tonnes per year of magnesium oxide (MgO) at its Driftwood Creek Magnesium Project, the Company has engaged engineering firm Hatch Ltd. to complete a scoping study for the purpose of selecting appropriate process and associated economics for the upgrading of magnesium oxide to magnesium metal.

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals Engages Hatch Ltd. for Magnesium Metal Study at Driftwood Creek, British Columbia

MGX Minerals Announces Advancement of Next Generation Zinc Air Fuel Cell Battery

MGX Minerals Announces Engagement of Dr. James G. Blencoe to Develop a Thermochemical Process for Extracting Lithium from Spodumene; Case Lake Lithium Project Drill Core to be Tested

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0181, up 3.43%, on 3,544,841 volume with 164 trades. The stock’s average daily volume over the past 60 days is 11,805,058, and its 52-week low/high is $0.0141/$0.16.

Global Payout Inc. (OTCPink:GOHE) is pleased to announce that its subsidiary MoneyTrac Technology, Inc. has begun the soft launch of MTRAC, a full-service banking solution powered by software technology features that the Company has acquired through its Joint Venture with GreenBox. Also today, NetworkNewsWire issued a report on the company detailing how, with a public initial blockchain offering (“PIBCO”) now underway, Global Payout Inc. is showcasing its innovative prowess.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

"Banking the UnbankableTM": MoneyTrac Soft Launches MTRAC, a Full Service Banking Solution for Cannabis

Global Payout Inc. (GOHE) Subsidiary’s Public Initial Blockchain Offering Showcases Company’s Fintech Capabilities

Enterprise Blockchain Solutions Emerging in Cross-Industry Sectors

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.34, even for the day, on 61,438 volume with 36 trades. The stock’s average daily volume over the past 60 days is 19,426, and its 52-week low/high is $0.01/$0.80.

On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis Enterprises Inc., a wholly owned subsidiary of Aurora Cannabis Inc.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

Preventive Medical Solutions Integrate with Major Cannabis Providers for Innovative Drug Delivery

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Grant of Australian Cannabis Importation Permits

PotNetwork Holdings Inc. (POTN)

The QualityStocks Daily Newsletter would like to spotlight PotNetwork Holdings Inc. (POTN). Today, PotNetwork Holdings Inc. closed trading at $0.379, off by 2.32%, on 3,378,582 volume with 869 trades. The stock’s average daily volume over the past 60 days is 14,452,300, and its 52-week low/high is $0.0006/$0.957.

PotNetwork Holding, Inc. (OTC Pink: POTN) announced today its wholly owned subsidiary, Diamond CBD, Inc., has reported that the Company has generated over 3 quarters of a million dollars, just within the first 10 days of February.

PotNetwork Holdings Inc. (POTN), based in Fort Lauderdale, Florida, is a holding company. The company's First Capital Venture Co. subsidiary is the owner of Diamond CBD, Inc., a producer of widely-distributed CBD hemp extracts and the primary operating entity of PotNetwork Holdings.

Diamond CBD is made up of chemists and other scientists focused on developing and producing very high-quality CBD oil over a broad range of products, based upon a thorough understanding of the various natural molecules found in hemp and their particular properties. All products are made with federally legal cannabidiol (CBD), and are available in hundreds of flavors and sizes. The company emphasizes a dedication to 100% natural lab-tested CBD ingredients, with a carefully monitored process all the way from the source farm, through production, and final delivery to retail shelves.

PotNetwork, through Diamond CBD, delivers products to all 50 states, as well as internationally, and controls 15 CBD brands. The company lists the following product brands:

  • Diamond CBD Gummies - Diamond CBD branded edible gummies made from crystal isolate. Available in a variety of flavors and gummy styles, including rainbow bites, mini fruit, gummy worms, sour snakes, and more.
  • Chill Gummies - Chill gummies are more robust than its counterpart, the "Relax" gummy line. Chill Gummies are edible CBD gummies available in a wide variety of flavors, strengths, and styles including gummy bears, sour snakes, rainbow bites, watermelon slices, sour snakes, rainbow bites, peanut butter chocolate, ocean gummies, gummy worms, gummy rings and more.
  • CBD Liquid Gold - CBD Liquid Gold is derived from naturally grown industrial hemp plants, certified by USA labs and then carefully mixed with a patent-pending (non-PG) all-natural base formulation.
  • Blue CBD - Blue CBD Crystal Isolate is a high-end vapor liquid and oral drop infused with premium CBD rich hemp oil. CBD liquids are Premium Gold quality and test at a 7X higher concentration.
  • Relax Gummies - Relax Gummies give a lighter effect of CBD with some natural flavors in comparison to its counterpart Chill Gummies. Relax Gummies are perfect for anyone with a sweet tooth that's looking for a lighter effect without sacrificing quality or taste.
  • Premium Hemp Liquid Pet - CBD For Pets is a new and refreshing product from Diamond CBD for all the millions of pets out there. It is an organic product and also has unique flavors in it.
  • CBD Re-Leaf - Disposable, long-lasting, and ready to Use CBD Re-leaf vaping pens available in a variety of flavors. Easily take CBD anywhere on the go.
  • Relax Extreme CBD - Relax Extreme CBD Oil provides a high-quality, high-strength dose of CBD through oral drops. It is very easy to use and works instantly. Simply place a drop under the tongue. Available in various strengths.
  • CBD Double Shot - CBD Double Shots are specifically designed for one-time use. Easily squeeze the package in your mouth and swallow; it's that simple. Take it anywhere you go. Relaxation is now conveniently in your pocket. Drinkable CBD shots provide a quick boost of relaxation on the go. Available in various flavors.
  • Chill Pill - CBD infused capsules available in various strengths. Relax, take a Chill Pill.

Over 1.2 million people currently use cannabis, including CBD products, for medical application, including cancer, epilepsy, and depression. By sourcing hemp outside the U.S., the company avoids current federally-based legal problems involved in growing cannabis domestically. In the meantime, PotNetwork Holdings continues to target a large and rapidly developing cannabis market, expanding from $6.5 billion in 2016, to an expected $30 billion in 2021 (Forbes), and $50 billion in 2026 (Bloomberg). The cannabidiol market alone is projected to reach $2.1 billion in 2020, a 700% increase from 2015. PotNetwork Holdings Inc. plans to expand its subsidiaries as well as make strategic acquisitions. Disclaimer

PotNetwork Holdings Inc. Company Blog

PotNetwork Holdings Inc. News:

PotNetwork Holding Inc. Generates Over $2 Million in Sales Revenue for February 2018, a 480% Increase on Last Year

PotNetwork Holding To Enter World’s Fastest Growing Market With Formation Of Blockchain Crypto Technology Subsidiary

PotNetwork Holding Unveils New Products At World’s Premiere Trade Show, ASD Market Week

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.002, off by 20.00%, on 6,756,573 volume with 58 trades. The stock’s average daily volume over the past 60 days is 2,700,696, and its 52-week low/high is $0.0005/$0.0085.

Software development and mobile solutions company Consorteum Holdings (OTC: CSRH) is ready to stake its claim of the booming mobile app market. An article discussing the company reads: “Following a year in which mobile gaming recorded remarkable growth, occupying nearly half the total market value of the gaming industry (http://nnw.fm/6g09W), some market watchers are predicting that worldwide consumer commitment to mobile app stores will grow about 30 percent year-over-year to exceed $110 billion by the end of 2018 (http://nnw.fm/iiJK7).

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company's commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ ("UMI") solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company's UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum's wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company's UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI's technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum's primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum's management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum's management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors. Disclaimer

Consorteum Holdings, Inc. Company Blog

Consorteum Holdings, Inc. News:

NetworkNewsBreaks – Consorteum Holdings, Inc. (CSRH) Targets Growing Mobile App Market Forecasted to Hit $110B by Year-end

Consorteum Holdings Inc.’s (CSRH) Gaming Subsidiary Seeks Expansion into European Markets

Consorteum Holdings, Inc. (CSRH) Enriching the Mobile Experience

AV1 Group, Inc. (AVOP)

The QualityStocks Daily Newsletter would like to spotlight AV1 Group, Inc. (AVOP). Today, AV1 Group, Inc. closed trading at $0.0208, up 10.05%, on 26,820 volume with 6 trades. The stock’s average daily volume over the past 60 days is 65,330 and its 52-week low/high is $0.015/$0.28.

AV1 Group, Inc. (AVOP), is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint in high-growth markets, the business model followed calls for incubating and supporting the best opportunities.

The company seeks to discover inspired entrepreneurs with innovative ideas that are poised for significant revenue generation. Management expertise can be seen in the development of embryonic-stage subsidiaries as the company brings a spectrum of backgrounds to the table with a significant resource of knowledge and experience to every venture. AV1 Group explores every opportunity to help each sector exceed its revenue goals while building close, active working relationships as it prepares each respective division to be a robust competitor within the various chosen markets.

AV1 Group companies include:

  • XFIRESmartSystems.com – Intelligent lighting solutions and wireless access for many different applications.
  • VaporHighUSA.com – Over 800 vaping products; bitcoin payments accepted.
  • DentalCannatizer.com – Revolutionary dual jet dental water jet integrates hemp oil infusing.
  • IntelligentLightingCorp.com – Comprehensive, energy-efficient lighting solutions.
  • CannaLighting.com – Wholly owned subsidiary building strategic relationships in the LED sector to provide solutions for grow houses and cultivation centers.
  • MJIQ – First, comprehensive, enterprise-grade integrated software suite being developed for the legal cannabis industry.
  • Hemptory.com – Engaging online destination for all hemp and cannabis related products and services.
  • Lawster.com – Puts consumers and small businesses in contact with legal services and service providers.
  • MJTestLabs.com – Under development website will serve cannabis dispensaries, laboratories and industry affiliates.

AV1 Group's business model delivers an advantage with internally-created projects that are poised for revenue generation and a cross-company revenue platform that enables the company to incubate and foster growth in early-stage subsidiaries under one umbrella. Disclaimer

AV1 Group, Inc. Blog

AV1 Group, Inc. News:

NetworkNewsBreaks – AV1 Group, Inc. (AVOP) Adds Strategic Corporate Advisor to Drive LED Division

AV1 Group, Inc. (AVOP) Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division

AV1 Group Announces Engagement of Strategic Corporate Advisor to Assist in Propelling LED Division


The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $1.23, off by 3.15%, on 73,332 volume with 91 trades. The stock’s average daily volume over the past 60 days is 130,319, and its 52-week low/high is $0.47/$2.70.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO, Inc. (EVIO) on Track for Exponential Growth within the Booming Legal Cannabis Industry

NetworkNewsBreaks – EVIO, Inc. (EVIO) Invests $800,000 in New Laboratory Equipment at Two Cannabis Testing Facilities

EVIO, Inc. (EVIO) Continues to Improve, Expanding EVIO Cannabis Testing Lab Services, Locations


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Trader Power News
(KBSF) +46.76%


(ISNS) +44.26%


MarketClub Analysis
(AKCA) +38.35%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251